1. Home
  2. KNSL vs STVN Comparison

KNSL vs STVN Comparison

Compare KNSL & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kinsale Capital Group Inc.

KNSL

Kinsale Capital Group Inc.

HOLD

Current Price

$390.71

Market Cap

8.8B

Sector

Finance

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$21.24

Market Cap

7.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNSL
STVN
Founded
2009
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Containers/Packaging
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
7.4B
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
KNSL
STVN
Price
$390.71
$21.24
Analyst Decision
Buy
Buy
Analyst Count
10
4
Target Price
$483.78
$25.38
AVG Volume (30 Days)
253.2K
338.7K
Earning Date
10-23-2025
11-06-2025
Dividend Yield
0.17%
0.30%
EPS Growth
16.09
19.61
EPS
20.35
0.60
Revenue
$1,802,839,000.00
$1,373,219,524.00
Revenue This Year
$19.56
$8.42
Revenue Next Year
$7.74
$9.52
P/E Ratio
$19.25
$34.83
Revenue Growth
18.10
6.97
52 Week Low
$349.00
$17.81
52 Week High
$521.13
$28.00

Technical Indicators

Market Signals
Indicator
KNSL
STVN
Relative Strength Index (RSI) 53.00 41.77
Support Level $349.00 $20.50
Resistance Level $401.15 $22.29
Average True Range (ATR) 10.66 1.10
MACD 4.11 -0.06
Stochastic Oscillator 81.05 21.08

Price Performance

Historical Comparison
KNSL
STVN

About KNSL Kinsale Capital Group Inc.

Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: